Search Results
Showing 14 of 14 results
Spreading HOPE Teva s Work to Improve Global Access to Medicine
Dr David G Poplack is internationally recognized as a leader in the field of pediatric oncology who launched Global HOPE in 2016 from Texas Children s Hospital the largest children s hospital in the US
Biopharmaceuticals
Teva Pharmaceuticals is investing in original biologic medicines and in biosimilars focusing central nervous system respiratory conditions and in oncology
Innovative Therapeutic Areas
Our therapeutic areas of pharmaceutical innovation include respiratory oncology neurodegenerative disorders migraine and more Learn more about Teva Pharmaceuticals
Meet Our People Beryl Ojwang
Beryl Ojwang MD MBA MPH Associate Medical Director Oncology Biosimilars North America Medical Affairs shares how artificial intelligence is bringing patient insights to Teva scientists
The Women I Mentored are My Legacy
Rose Crane a Board member at Teva has dedicated her career to improving lives as a pharma executive She shares her experience tips and optimism
Teva Expands Partnership to Bring Critical Medicines to Children Living with Cancer
Teva believes medicine should always be accessible We are partnering with Texas Children s Hospital s Global HOPE and Direct Relief to provide needed treatment to children with cancer and blood disorders
Biopharmaceuticals at Teva
Discover what biopharmaceuticals are and how Teva Pharmaceuticals does invest in this domain
Teva Worldwide
Teva Pharmaceuticals global network of employees and manufacturing facilities works around the clock to deliver products to patients in more than 60 countries
Advancing Access to Essential Medicines
Read the latest and past featured stories from Teva Pharmaceuticals and discover the newest developments of the health section
